Triumeq
Abacavir, Dolutegravir, Lamivudine
600/50/300mg
Abacavir, dolutegravir and lamivudine in one tablet, used in the management of HIV infection. Three agents against three stages of the viral cycle.
From$8.69/ tabletView
HIV Management
Antiretroviral medicines can be used to treat HIV or, in specific combinations, to prevent acquisition. Treatment, pre-exposure prophylaxis and post-exposure prophylaxis are different pathways and require HIV testing and clinical follow-up.
Tenofovir Emtricitabine
300/200mg
Tenofovir with emtricitabine as a 300/200mg film-coated tablet, for HIV infection and pre-exposure prophylaxis. Two reverse transcriptase inhibitors.
From$1.84/ tabletView
Epivir HBV
100mg
Lamivudine 100mg film-coated tablets, the hepatitis B strength, used in the management of chronic hepatitis B. It inhibits the viral reverse transcriptase.
From$1.73/ tabletView
Darunavir Tablets
600 · 800mg
Darunavir 600mg and 800mg film-coated tablets, used in the management of HIV infection. A protease inhibitor that halts assembly of new virus.
From$9.35/ tabletView
Key points
- HIV treatment uses a planned regimen; taking one medicine alone or switching individual components can lead to treatment failure or resistance.
- PrEP is for people confirmed not to have HIV, while PEP is a time-sensitive option after a recent possible exposure.
- A new rash with fever, breathing difficulty, jaundice or severe weakness after starting medicine needs urgent assessment.
The listings are for comparison; suitability and supply depend on clinician and pharmacy checks, stock, destination rules and any prescription requirements.
How the medicine groups differ
- Nucleoside or nucleotide components: tenofovir disoproxil, lamivudine and abacavir may form part of a combination selected after clinical checks.
- Integrase inhibitors: dolutegravir and raltegravir block a different stage of viral replication and are used with other active medicines.
What these medicines are used for
The category includes medicines used for HIV infection and pre-exposure prophylaxis. Some components also have a role in chronic hepatitis B, which changes how they should be started or stopped.
Important safety checks
HIV status, kidney and liver function, hepatitis B status, pregnancy and medicine interactions should be reviewed. Do not stop treatment or HBV-active medicine without clinical advice; interruption can allow HIV to rebound or hepatitis B to flare.
When to seek urgent care
Seek prompt clinical care after a recent possible HIV exposure because PEP is time-sensitive. Get urgent help for breathing difficulty, facial swelling, a widespread rash with fever, jaundice, severe abdominal pain or marked weakness.